Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

EXPERIMENTAL CONDITION - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:peripheral myelin protein 2 peptide 58-81
go back to main search page
Accession:XCO:0000291 term browser browse the term
Definition:A condition in which the major influencing factor is the peptide (KNTEISFKLGQEFEETTADNRKTK) representing residues 58 to 81 of peripheral myelin protein 2, a fatty acid and cholesterol binding protein which together with myelin basic protein constitutes a major fraction of the peripheral nervous system myelin proteins.
Synonyms:related_synonym: P2 58-81;   P2 peptide 58-81



show annotations for term's descendants           Sort by:
peripheral myelin protein 2 peptide 58-81 term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Ean1 Experimental allergic neuritis QTL 1 IDA RGD PMID:15342198 RGD:2306736

Term paths to the root
Path 1
Term Annotations click to browse term
  experimental condition 2376
    chemical 712
      chemical with specified function 517
        antigen 158
          peptide/protein antigen 44
            peripheral myelin protein 2 1
              peripheral myelin protein 2 peptide 58-81 1
Path 2
Term Annotations click to browse term
  experimental condition 2376
    chemical 712
      chemical with specified function 517
        antigen 158
          myelin 8
            peripheral nerve myelin 6
              peripheral myelin protein 2 1
                peripheral myelin protein 2 peptide 58-81 1
paths to the root